Anabolic–androgenic steroids (AAS) are a class of hormones that are widely abused for
their muscle-building and strength-increasing properties in high, nontherapeutic, dosages …

Sarcopenia, now with its own International Classification of Diseases, 10th Revision (ICD-
10) code, is of importance clinically and should be accounted for in research studies in …

Results Whereas 20% of patients had sarcopenia, low muscle mass and low muscle
strength alone were observed in a further 24% and 15% of patients, respectively. Old age …

With aging and other muscle wasting diseases, men and women undergo similar
pathological changes in skeletal muscle: increased inflammation, enhanced oxidative …

Sarcopenia, a condition characterized by loss of skeletal muscle mass and function, has
important clinical ramifications. We aimed to map the existing literature about prevalence …

Muscle wasting (or sarcopenia) is a common feature of the uremic phenotype and
predisposes this vulnerable patient population to increased risk of comorbid complications …

Sarcopenia or muscle wasting is a progressive and generalized skeletal muscle disorder
involving the accelerated loss of muscle mass and function, often associated with muscle …

Abstract The South Asian population is rapidly ageing and sarcopenia is likely to become a
huge burden in this region if proper action is not taken in time. Several sarcopenia …

Recent studies show that a high BMI is not protective for all patients with chronic kidney
disease and is associated with poor physical functioning and frailty. Visceral adiposity is …

Sarcopenia is characterized by a gradual slowing of movement due to loss of muscle mass
and quality, decreased power and strength, increased risk of injury from falls, and often …